SignalTech/AI
Anthropic Buys a Small Drug Startup as It Pushes Deeper Into Biotech
Anthropic's acquisition of a drug startup signals deeper biotech expansion.
Context
What happened: Anthropic said it acquired Mithril Medicine, a one-person startup developing treatments for two rare forms of muscular dystrophy, a sign of the AI developer's growing ambitions in drug discovery.
Why it matters: The company also said it is working with Bristol Myers Squibb, BigHat Biosciences and four other partners, indicating its push into biotech extends beyond the acquisition.
What changed
Anthropic said it acquired Mithril Medicine, a one-person startup developing treatments for two rare forms of muscular dystrophy, a sign of the AI developer's growing ambitions in drug discovery.
Why it matters
The company also said it is working with Bristol Myers Squibb, BigHat Biosciences and four other partners, indicating its push into biotech extends beyond the acquisition.